Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


New insights into CAR T-cell therapy's potential side effects

Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer

Oct. 11, 2017 | By Fred Hutch staff

Detailed studies of two potential side effects of an emerging cancer immunotherapy could eventually help make this strategy, CAR T-cell therapy, safer for patients. The studies examined cytokine release syndrome and neurologic toxicities.

View story >


How techies in Washington state can help find cancer cures

The Hutch's Dr. Gary Gilliland speaks at GeekWire Summit highlighting innovations in the Northwest and beyond

Oct. 10, 2017 | By Susan Keown / Fred Hutch News Service

Washington state is known as the home for innovation in aviation and in coffee. But could it be known as the capital of cancer cures, too? That’s the question — and the challenge — that Fred Hutchinson Cancer Research Center President and Director Dr. Gary Gilliland posed to hundreds of tech industry and business leaders today at the 2017 GeekWire Summit in Seattle.

View story >


Mourning the loss of Dr. Oliver 'Ollie' Press

Lymphoma physician-scientist, leader and mentor made lifesaving contributions to the development of targeted cancer therapies

Oct. 2, 2017 | by Susan Keown / Fred Hutch News Service

Dr. Oliver Press died of complications from glioma, a brain cancer. Press was a physician-scientist who made foundational contributions to the development of targeted therapies for blood cancers.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 29, 2017

Dr. Jennifer Adair, a clinical researcher at Fred Hutch, spoke recently at TEDxNashville about her vision of making gene therapy more accessible and affordable for treating diseases ranging from glioblastoma to HIV.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.